Botulinum neurotoxin type a injections for vaginismus secondary to vulvar vestibulitis syndrome

Obstetrics and Gynecology

Volumn 114, Issue 5, 2009, Pages 1008-1016

  Bertolasi, Laura ^a   Frasson, Emma ^a   Cappelletti, Jee Yun ^a   Vicentini, Silvana ^a   Bordignon, Monia ^a   Graziottin, Alessandra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; DRUG EFFICACY; ELECTROMYOGRAM; ELECTROMYOGRAPHY; FEMALE; HUMAN; LEVATOR ANI MUSCLE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE; TREATMENT FAILURE; TREATMENT OUTCOME; VAGINISM; VISUAL ANALOG SCALE; VULVAR VESTIBULITIS;

ADULT; BOTULINUM TOXIN TYPE A; COITUS; DYSPAREUNIA; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INTESTINAL DISEASES; NEUROMUSCULAR AGENTS; PELVIC FLOOR; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; URINATION DISORDERS; VAGINISMUS; VULVAR VESTIBULITIS;

EID: 73549094957     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181bb0dbb     Document Type: Article

References (50)

1. Friedrich EGJr. Vulvar vestibulitis syndrome. J Reprod Med 1987;32:110-114
2. Bergeron S, Binik YM, Khalifé S, Pagidas K, Glazer HI. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria Obstet Gynecol 2001;98:45-51.
3. 3. Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, et al. Revised definitions of women's sexual dysfunction. J Sex Med 2004;1:40-48 (Pubitemid 40424665)
4. Munday P, Buchan A. Vulval vestibulitis. BMJ 2004;328:1214-1215
5. Vincenti E, Graziottin A. Sexual pain disorders: dyspareunia and vaginismus. In: Porst H, Buvat J, editors. Standard practice in sexual medicine. Oxford (UK): Blackwell; 2006. p. 342-350
6. Graziottin A, Rovei V. Sexual pain disorders. In: Tepper M, Owens AF, editors. Sexual health. Westport (CT): Praeger; 2007. p. 287-313.
7. Frasson E, Graziottin A, Priori A, Dall'ora E, Didonè G, Garbin EL, et al. Central nervous system abnormalities in vaginismus. Clin Neurophysiol 2009;120:117-122
8. 8. Abramov L, Wolman I, David MP. Vaginismus: an important factor in the evaluation and management of vulvar vestibulitis syndrome. Gynecol Obstet Invest 1994;38:194-197 (Pubitemid 24297708)
9. Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1999;48: 270-275
10. Bohm-Starke N, Hilliges M, Blomgren B, Falconer C, Rylander E. Increased blood flow and erythema in posterior vestibular mucosa in vulvar vestibulitis(1). Obstet Gynecol 2001;98:1067-1074
11. Graziottin A, Serafini A. HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions. J Sex Med 2009;6:633-645
12. Lamont JA. Vaginismus. Am J Obstet Gynecol 1978;131:633-636
13. Brin MF, Vapnek JM. Treatment of vaginismus with botulinum toxin injections [published erratum appears in Lancet 1997;349:656]. Lancet 1997;349:252-253
14. 14. Shafik A, El-Sibai O. Study of the pelvic floor muscles in vaginismus: a concept of pathogenesis. Eur J Obstet Gynecol Reprod Biol 2002;105:67-70. (Pubitemid 35335323)
15. Bertolasi L, Frasson E, Bottanelli M, Vicentini S, Didonè G, Graziottin A. Coexisting idiopathic cervical dystonia and primary vaginismus: a case report. J Neurol 2008;255:443-445
16. Graziottin A, Brotto L. Vulvar vestibulitis syndrome: a clinical approach [published erratum appears in J Sex Marital Ther 2004;30:303]. J Sex Marital Ther 2004;30:125-139
17. 17. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004;58:171-178 (Pubitemid 39370417)
18. 18. Halperin R, Zehavi S, Vaknin Z, Ben-Ami I, Pansky M, Schneider D. The major histopathologic characteristics in the vulvar vestibulitis syndrome. Gynecol Obstet Invest 2005;59:75-79 (Pubitemid 40868074)
19. 19. Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely RH. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol 2004;104:126-133 (Pubitemid 40458915)
20. Graziottin A. Dyspareunia and vaginismus: review of the literature and treatment. Curr Sex Health Rep 2008;5:43-50.
21. Vincenti E, Graziottin A. Management by anesthetic blocks. In: Goldstein I. Meston C. Davis S. Traish A, editors. Women's sexual function and dysfunction: study, diagnosis and treatment. New York (NY): Taylor & Francis; 2006. p. 524-528
22. Rapkin AJ, McDonald JS, Morgan M. Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome. Am J Obstet Gynecol 2008;198:41.e1-5
23. Goetsch MF. Surgery combined with muscle therapy for dyspareunia from vulvar vestibulitis: an observational study. J Reprod Med 2007;52:597-603.
24. 24. Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol 2006;108:915-923 (Pubitemid 44498253)
25. Peters K, Girdler B, Carrico D, Ibrahim I, Diokno A. Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:665-669
26. Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic feedback of pelvic floor musculature. J Reprod Med 1995;40:283-290.
27. 27. Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, et al. A randomized comparison of group cognitivebehavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306. (Pubitemid 32241151)
28. Graziottin A. Female sexual dysfunction: treatment, in: Bø K, Berghmans B, Mørkved S, Van Kampen M, editors. Evidencebased physical therapy for the pelvic floor-bridging science and clinical practice. Oxford (UK): Elsevier; 2007. p. 277-287.
29. Dressier D, Adib Saberi F. Botulinum toxin: mechanisms of action. Eur Neurol 2005;53:3-9.
30. 30. Ghazizadeh S, Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstet Gynecol 2004;104:922-925 (Pubitemid 40458751)
31. 31. Shafik A, El-Sibai O. Vaginismus: results of treatment with botulinum toxin. J Obstet Gynaecol 2000;20:300-302 (Pubitemid 30333012)
32. Bertolasi L, Frasson E, Graziottin A. Botulinum toxin treatment of pelvic floor disorders and genital pain in women. Curr Womens Health Rev 2008;4:180-187
33. 33. Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol 2004;44:46-50. (Pubitemid 38239698)
34. 34. Romito S, Bottanelli M, Pellegrini M, Vicentini S, Rizzuto N, Bertolasi L. Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest 2004;58:164-167 (Pubitemid 39370415)
35. 35. Thomson AJ, Jarvis SK, Lenart M, Abbott JA, Vancaillie TG. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. BJOG 2005;112:247-249 (Pubitemid 40188257)
36. 36. Brown CS, Glazer HI, Vogt V, Menkes D, Bachmann G. Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data. J Reprod Med 2006; 51:635-641 (Pubitemid 44300075)
37. 37. Dykstra DD, Presthus J. Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study. J Reprod Med 2006;51:467-470 (Pubitemid 43911964)
38. 38. Gunter J, Brewer A, Tawfik O. Botulinum toxin a for vulvodynia: a case report. J Pain 2004;5:238-240 (Pubitemid 38881118)
39. Yoon H, Chung WS, Shim BS. Botulinum toxin A for the management of vulvodynia. Int J Impot Res 2007;19:84-87
40. Binnie CD, Cooper R, Fowler CJ, Mauguière F, Prior PF. Electromyography and nerve conduction. In: Osselton JW, editor. Clinical neurophysiology: EMG, nerve conduction and evoked potentials. 1st ed. Oxford (UK): Butterworth-Heinemann; 1995. p. 43-322.
41. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. 3rd ed. New York (NY): Oxford University Press; 2001. p. 380.
42. 42. Rosen R, Brown C, HeimanJ, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208. (Pubitemid 30194541)
43. Nappi RE, Albani F, Vaccaro P, Gardella B, Salonia A, Chiovato L, et al. Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. Gynecol Endocrinol 2008;24:214-219
44. 44. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233 (Pubitemid 126433231)
45. 45. Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 1996;39:681-685 (Pubitemid 26181138)
46. 46. van der Velde J, Laan E, Everaerd W. Vaginismus, a component of a general defensive reaction. An investigation of pelvic floor muscle activity during exposure to emotion-inducing film excerpts in women with and without vaginismus. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:328-331 (Pubitemid 34071889)
47. 47. Peters KM, Killinger KA, Carrico DJ, Ibrahim IA, Diokno AC, Graziottin A. Sexual function and sexual distress in women with interstitial cystitis: a case-control study. Urology 2007;70:543-547 (Pubitemid 47464499)
48. Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol 2008;179:1031-1034
49. Ramsay AK, Small DR, Conn IG. Intravesical botulinum toxin type A in chronic interstitial cystitis: results of a pilot study. Surgeon 2007;5:331-333
50. Kennedy CM, Nygaard IE, Bradley CS, Galask RP. Bladder and bowel symptoms among women with vulvar disease: are they universal? J Reprod Med 2007;52:1073-1078